Testing version — LOERadar is in active testing. Features and data may change.

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE) | LOERadar

Viewing data from:

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

ANDA

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | A090958 | CIPLA LTD

1 strength0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Feb 27, 2014	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 200MG;300MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 2, 2021

No patent or exclusivity listings for this strength.